ACS Medicinal Chemistry Letters · 2018 · 34 citations · 12 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryStructure-activity RelationshipsBlood Pressure ManagementCardiovascular PharmacologyHypertension PharmacotherapyLead Compound DesignPotency OptimizationStructure-activity Relationship AnalysisAngiotensin Ii Receptor BlockersAntihypertensive Drug TherapyAntihypertensive PharmacologyBenzimidazole ChemistryBenzimidazole SynthesisBlood PressureBlood Pressure Pharmacodynamics
A series of new angiotensin II receptor 1 antagonists were prepared. They displayed nanomolar affinity to AT1 receptor and could decrease blood pressure efficiently in spontaneously hypertensive rats. Among them, compounds 1b and 2b could reduce the blood pressure with more or equal potency compared to Losartan. So, compounds 1b and 2b could be considered as potential antihypertension drug candidates.
12
Hypertension: Pathophysiology, Diagnosis, and Management
William B. White · JAMA · 1991 · 948 citations
Andrew T. Chiu, Dale E. McCall, William A. Price et al. · Journal of Pharmacology and Experimental Therapeutics · 1990 · 317 citations
Uwe J. Ries, Gerhard Mihm, Berthold Narr et al. · Journal of Medicinal Chemistry · 1993 · 203 citations · Full text
S Kim, Kensuke Ohta, Akinori Hamaguchi et al. · Journal of Pharmacology and Experimental Therapeutics · 1995 · 148 citations
Andrea Cappelli, Gal.La Pericot Mohr, Andrea Gallelli et al. · Journal of Medicinal Chemistry · 2004 · 80 citations · Full text